Octagon Capital Advisors’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Octagon Capital Advisors’s Portfolio VIE Stock Details VIE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-85,409	Closed	-$3.07M	–	38
2020 Q4	$3.07M	Buy	+85,409	New	+$2.99M	1.06%	25

Octagon Capital Advisors's VIE Position: Q1 2021 in Review

Octagon Capital Advisors sold out of Viela Bio, Inc. Common Stock (VIE) in Q1 2021, closing a stake of 85,409 shares — an estimated $3.07M sold.

Octagon Capital Advisors first reported a position in VIE in Q4 2020 and held it in 1 quarter. The position peaked at $3.07M in Q4 2020. 0 funds tracked by Wall St. Rank hold VIE as of Q1 2021.

Octagon Capital Advisors reported no remaining Viela Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Octagon Capital Advisors sold 85,409 Viela Bio, Inc. Common Stock shares in Q1 2021, an estimated $3.07M.
Octagon Capital Advisors first reported a position in Viela Bio, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Octagon Capital Advisors's Viela Bio, Inc. Common Stock position peaked at $3.07M in Q4 2020.
0 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q1 2021.

Based on Octagon Capital Advisors's 13F filing for Q1 2021, filed 17 May 2021.